Every year, America’s medical research pipeline produces new treatments, new technologies and new ways to improve patient care. Often, the real challenge is ensuring policy keeps pace with these ...

Panel biomarker testing can unlock some of the mysteries of treating patients so that they experience fewer side effects, better quality of life, longer survival rates and potentially, lower costs. At ...

Biomarkers are traits that doctors measure in your blood, body fluids, and tissues. Experts also call them molecular markers and signature molecules. They can be signs of conditions, diseases, normal ...

Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a one-size-fits-all approach. Biomarkers serve diagnostic, prognostic, and predictive roles ...

IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CET, April 4, 2017 - MDxHealth SA (Euronext: MDXH.BR), today announced that it has signed an exclusive licensing deal with Ghent University in Belgium for its ...

In oncology drug development, biomarker-driven studies are pivotal, enabling the selection of patient populations most likely to benefit from specific therapeutic interventions. These studies have ...

AstraZeneca has used artificial intelligence to devise a unique biomarker for its Daiichi Sankyo-partnered datopotamab deruxtecan (Dato-DXd), hoping to differentiate the antibody-drug conjugate (ADC) ...

Biomarker changes that occur in the period between normal cognition and the diagnosis of sporadic Alzheimer’s disease have not been extensively investigated in longitudinal studies. We conducted a ...

European funding for cancer research has led to some interesting results in recent years. A unique strategic research initiative in Sweden, called BioCARE (Biomarkers in Cancer Medicine), currently ...

Biomarkers (a shortened term for biological markers) are measurable characteristics of a certain biological condition or response to a medical or environmental exposure. Some biomarkers, such as blood ...